Lv1
40 积分 2024-03-30 加入
Reprogramming CD22 CAR-T cells in vivo using CD8-targeted mRNA-LNPs to treat hematological malignancies
9天前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
17天前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
18天前
已完结
Tonic signaling in CAR-T therapy: the lever long enough to move the planet
1个月前
已完结
The CD33 splice isoform lacking exon 2 as therapeutic target in human acute myeloid leukemia
1个月前
已完结
CD33: increased inclusion of exon 2 implicates the Ig V-set domain in Alzheimer's disease susceptibility
1个月前
已完结
Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells
1个月前
已完结
Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia
1个月前
已完结
Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers
1个月前
已完结
Autologous CD19 CAR T-cell therapy for pediatric and adult systemic lupus erythematosus: a phase 1/2 trial
2个月前
已完结
皖公网安备34019202002308
